VivoSim Labs (VIVS) Profit After Tax (2010 - 2026)
VivoSim Labs (VIVS) posted Profit After Tax of -$1.3 million for Q2 2026, up 76.79% on a QoQ basis from -$5.8 million in Q1 2026, and up 52.94% year-over-year from -$874869.8 in Q2 2025.
Analysis
VivoSim Labs (VIVS) Profit After Tax (2010 - 2026) Analysis & Trends
VivoSim Labs has reported Profit After Tax for 17 years, with the latest figure at -$1.3 million in Q2 2026.
- On a quarterly basis, Profit After Tax rose 52.94% year-over-year to -$1.3 million in Q2 2026; TTM through Jun 2026 was -$12.3 million, a 520.62% decrease from a year earlier, with the FY2026 full-year figure at -$13.8 million, down 456.39% from the prior year.
- Profit After Tax was -$1.3 million for Q2 2026 at VivoSim Labs, up from -$5.8 million in the prior quarter.
- The five-year high for Profit After Tax was $6.9 million in Q1 2025, with the low at -$7.5 million in Q1 2023.
- Average Profit After Tax over 5 years is -$2.9 million, with a median of -$3.2 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Profit After Tax slumped 290.32% in 2023, then jumped 324.95% in 2025.
- Over 5 years, Profit After Tax stood at -$3.3 million in 2022, then dropped by 10.42% to -$3.6 million in 2023, then climbed by 4.33% to -$3.4 million in 2024, then gained by 21.95% to -$2.7 million in 2025, then soared by 50.28% to -$1.3 million in 2026.
- The last three Profit After Tax figures came in at -$1.3 million (Q2 2026), -$5.8 million (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 258.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 72.58 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -1.48 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -57.32 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -426,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -4.36 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -1.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.34 Mn |
| Mar 31, 2026 | -5.76 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Sep 30, 2025 | -2.55 Mn |
| Jun 30, 2025 | -2.84 Mn |
| Mar 31, 2025 | 6.85 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Sep 30, 2024 | -2.55 Mn |
| Jun 30, 2024 | -3.34 Mn |
| Mar 31, 2024 | -3.05 Mn |
| Dec 31, 2023 | -3.60 Mn |
| Sep 30, 2023 | -4.00 Mn |
| Jun 30, 2023 | -4.03 Mn |
| Mar 31, 2023 | -7.46 Mn |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | -3.32 Mn |
| Jun 30, 2022 | -3.22 Mn |
| Mar 31, 2022 | -1.91 Mn |
| Dec 31, 2021 | -3.50 Mn |
| Sep 30, 2021 | -3.51 Mn |